Why Did In8bio Inc. (INAB) Plunge 12.84% Amid Market Volatility?

In8bio Inc. (INAB) experienced a significant drop of 12.84% in pre-market trading on June 2, 2025, reflecting a notable decline in investor sentiment.

In8bio Inc. has been under scrutiny due to its recent financial performance and strategic decisions. The company's market capitalization has been fluctuating, which has raised concerns among investors about its long-term viability. The biotechnology sector, in which In8bio operates, has seen mixed results, with some companies thriving while others struggle to maintain their market position.

In8bio's recent performance has been influenced by broader market trends and industry-specific challenges. The biotechnology industry is known for its volatility, and In8bio's stock price has been particularly sensitive to market fluctuations. Investors are closely monitoring the company's progress and strategic initiatives, as any positive developments could potentially reverse the recent downward trend.